Study of TOP1630 for Dry Eye Syndrome

Clinical trial NCT03833388 · COMPLETED

Trial details

NCT number: NCT03833388
Sponsor: Topivert Pharma Ltd
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Dry Eye Syndrome

Start date: 2019-02-13
Primary completion: 2019-05-14
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.